Global Genome Editing Market (2018-2023) to Grow at a CAGR of 14.5% - Technological Advancements are Fuelling Growth - ResearchAndMarkets.com

DUBLIN--()--The "Global Genome Editing Market - Segmented by Technology, Application, End-User, and Geography - Growth, Trends, and Forecast (2018 - 2023)" report has been added to ResearchAndMarkets.com's offering.

The global genome editing market is expected to register a CAGR of 14.5% during the forecast period, 2018 to 2023.

Genetic modification has provided an approach for reverse genetics, analyzing gene function, and linking DNA sequence to phenotype. Traditional methods are now becoming obsolete, due to progress in the genome sequencing technologies, as a result of inefficient, time consuming, and labor intensive methods.

Recent technologies, like ZFN, TALEN, and CRISPR/Cas9 nuclease, can initiate genome editing easily and precisely, with no limitations by the organism. These instruments have offered intriguing possibilities for conducting large-scale experiments. Thus, technological advancements are fuelling the growth of the genome testing market.

Additionally, rising incidences of chronic disease and increase in the demand for synthetic genes are driving the genome editing market.

North America dominates the market due to the factors, such as, increasing use of genetically modified crops and the development of gene therapy in the United States. Additionally, genetic diseases, like cystic fibrosis, occur at a frequency of 1 in 2,500 birth in the United States.

Key Topics Covered

1. Introduction

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview

6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

7. Market Segmentation

8. Competitive Landscape

9. Key Players

  • Thermo Fisher Scientific Inc.
  • Sangamo Biosciences Inc.
  • Genscript Usa Inc.
  • Horizon Discovery Group Plc
  • Merck & Co.
  • Origene Technologies Inc.
  • Transposagen Biopharmaceuticals Inc.
  • New England Biolabs Inc.
  • Lonza Group Ltd
  • Integrated DNA Technologies Inc.

10. Outlook of the Market

For more information about this report visit https://www.researchandmarkets.com/research/zv2q3r/global_genome?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Genomics

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Genomics